Fundació La Marató de TV3   Report issue

Foundation Phase 2 Phase 3
Founded: Spain (1996)

Organization Overview

First Clinical Trial
2017
NCT03833336
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fundació La Marató de TV3

Active Ingredients

Drugs in Phase 3 Trials (3)

ferric carboxymaltose (Injectafer) (1 trial)

ferroglycine sulfate (1 trial)

sucrosomial iron (1 trial)

Drugs in Phase 2 Trials (1)

alteplase (Activase) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 3)

Heart Failure (Phase 3)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4